SCHEMBL7656320

SCHEMBL7656320

CC(C)(C)OC(=O)ON=C(N)c1ccc(NC(=O)c2ccccc2-c2ccccc2C(=O)OCc2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.43
RAB9A P51151 3/20 0.43
KMT2A Q03164 3/20 0.43
ALDH1A1 P00352 4/20 0.41
HPGD P15428 2/20 0.41
HTT P42858 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 1/20 0.39
PLAU P00749 1/20 0.38
PLAT P00750 1/20 0.38
F2 P00734 1/20 0.38
F10 P00742 1/20 0.38
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657290 0.90 SMN1; SMN2 (0.50) GAARAB9AKMT2AALDH1A1HPGD
SCHEMBL7660125 0.86 CYP2C9 (0.52) GAAKMT2ACYP2C9MEN1PLAU
SCHEMBL7663254 0.80 ALDH1A1 (0.47) GAARAB9AKMT2AALDH1A1HPGD
SCHEMBL7658212 0.79 PLAU (0.60) GAARAB9AKMT2AALDH1A1CYP2C9
SCHEMBL7656726 0.79 F3 (0.57) F2F10PRSS1PRSS2F7
SCHEMBL7663757 0.75 F7 (0.47) PLAUPLATF2F10PRSS1
SCHEMBL7658129 0.74 F7 (0.59) PLAUPLATF2F10PRSS1
SCHEMBL7856066 0.74 F7 (0.54) KMT2ANPSR1MAPTL3MBTL1MEN1
SCHEMBL7658587 0.74 F2 (0.53) GAARAB9AKMT2AMEN1PLAU
SCHEMBL7947648 0.74 PNLIP (0.56) GAARAB9AKMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed